
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
Cruising Solo All over the Planet: An Excursion of Self-Disclosure
Nearly 16,000 New York City nurses prepare to strike as contract talks stall
Don't plan to cook on Thanksgiving? Here are the restaurants and fast food places that are scheduled to be open
Lily Allen 2026 'West End Girl' arena tour: How to get tickets, prices and more
Treasure trove found in Egyptian tomb solves ancient mystery
WHO suspends Gaza medical evacuations after contractor killed by Israeli troops
19 Peculiar Films You Shouldn't Watch With Your Mum
The Best Cell phone Brands for Tech Lovers
Vote In favor of Your Favored Kind Of Cheddar













